Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic developments in pancreatic cancer
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 135

Showing 51-75 of 135 citing articles:

ENO1-Mediated Deoxycytidine Synthesis and Gemcitabine Resistance by Stabilizing RRM2 in Pancreatic Cancer
Chao Yu, Hao Wang, Liwen Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
Junjian Shen, Qin Li, Lei Li, et al.
Insights into Imaging (2025) Vol. 16, Iss. 1
Open Access
Network pharmacology and AI in cancer research uncovering biomarkers and therapeutic targets for RALGDS mutations
S. Mohammed Zaidh, Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Contributions of Low-frequency-mutated Genes in Pancreatic Tumorigenesis and Their Implications in Precision Cancer Therapy
Shih‐Han Hsu, Tzu-Lei Kuo, Ming‐Chuan Hsu, et al.
Journal of Cancer Research and Practice (2025) Vol. 12, Iss. 1, pp. 1-5
Open Access
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
R. Ramesh, Hadida Yasmin, Pretty Ponnachan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Correlation of MRI characteristics with KRAS mutation status in pancreatic ductal adenocarcinoma
Junjian Shen, Xingxing Wang, Kaifan Yu, et al.
Abdominal Radiology (2025)
Closed Access
Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E
Junqian Zhang, Xiaobo Zhang, R. Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Persistent Health Inequalities in the Burden of Gastrointestinal Cancers Among the Elderly From 1990 to 2021: A Population-Based Study
Zijian Qiu, S C Yu, Y. Lou, et al.
Cancer Control (2025) Vol. 32
Open Access
Engineered radiation-sensitive probiotic for synergistic tumor cell cycle blockade and immunomodulation to potentiate radio-immunotherapy in pancreatic cancer
Weiqin Yao, Shi‐Man Zhang, Xuqi Hu, et al.
Materials Today (2025)
Closed Access
Pancreatic cancer
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Pancreatic cancer subtyping - the keystone of precision treatment
Zeyang Fan, Yao Xiao, Yan Du, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Establishment of a nomogram based on Lasso Cox regression for albumin combined with systemic immune-inflammation index score to predict prognosis in advanced pancreatic carcinoma
Min Xu, Long Yu, Pisin Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer
Tiantian Zhang, Yangyang Zhou, Yue Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
Wenyi Yan, Yujing Xuan, Rui Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 882-882
Open Access
Chemoimmunotherapy synergism: mechanisms and clinical applications
Rahaman Shaik, Sai Manasa Chittepu, Meghana Tarapatla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases
Xianlong Chen, Shanyue Sun, Jiapeng Zhao, et al.
British Journal of Cancer (2025)
Open Access
Establishment and validation of an immune-related nomogram for the prognosis of pancreatic adenocarcinoma
Kan Wang, Yunkun Lu, Yanfei Cao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Solute Carrier Superfamily as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma
Sang Yeon Cho, Hyuk Soo Eun, Jaejeung Kim, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 463-463
Open Access
NIR pH-Responsive PEGylated PLGA Nanoparticles as Effective Phototoxic Agents in Resistant PDAC Cells
Degnet Melese Dereje, Francesca Miele Bianco, Carlotta Pontremoli, et al.
Polymers (2025) Vol. 17, Iss. 8, pp. 1101-1101
Open Access
Targeting protein glycosylation and cholesterol metabolism in chemoresistant pancreatic cancer
Yunguang Li, Shijie Tang, Huan Wang, et al.
(2025)
Closed Access
Identification of prognostic and therapeutic biomarkers associated with macrophage and lipid metabolism in pancreatic cancer
Lili Wu, Feihong Liang, Changgan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Discovery of Potent PDEδ/NAMPT Dual Inhibitors: Preclinical Evaluation in KRAS Mutant Pancreatic Cancer Cells
Yaojin Zhu, Zhenqian Chen, Guoyuan Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study
Norbert Marschner, Nils Haug, Susanna Hegewisch‐Becker, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 9, pp. 1629-1640
Open Access | Times Cited: 3

Scroll to top